Of note, loss of tumor suppressor KEAP1 in lung cancers leads to glucose dependency through upregulating cystine metabolism-mediated NADPH consumption (82), suggesting an emerged metabolic vulnerability due to genetic alteration of such gene. Here, KEAP1 is linked to lung cancer.